Aravive Inc [NASDAQ: ARAV] loss -9.08% on the last trading session, reaching $0.13 price per share at the time. The company report on August 2, 2023 at 4:01 PM that Aravive Announces Top-Line Results from Phase 3 AXLerate-OC Study of Batiraxcept in Platinum-Resistant Ovarian Cancer.
Trial did not meet primary endpoint of progression-free survival.
Cash at the end of Q2 of approximately $18M (unaudited) is expected to be sufficient to fund operations into early Q4 2023.
Aravive Inc represents 59.84 million in outstanding shares, while the company has a total market value of $9.28 million with the latest information. ARAV stock price has been found in the range of $0.1234 to $0.1331.
If compared to the average trading volume of 7.00M shares, ARAV reached a trading volume of 3179866 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Aravive Inc [ARAV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ARAV shares is $7.42 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ARAV stock is a recommendation set at 2.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for Aravive Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 17, 2023.
The Average True Range (ATR) for Aravive Inc is set at 0.03, with the Price to Sales ratio for ARAV stock in the period of the last 12 months amounting to 1.01.
Trading performance analysis for ARAV stock
Aravive Inc [ARAV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -18.12. With this latest performance, ARAV shares dropped by -0.71% in over the last four-week period, additionally sinking by -94.52% over the last 6 months – not to mention a drop of -86.22% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ARAV stock in for the last two-week period is set at 26.41, with the RSI for the last a single of trading hit 29.36, and the three-weeks RSI is set at 26.18 for Aravive Inc [ARAV]. The present Moving Average for the last 50 days of trading for this stock 0.5175, while it was recorded at 0.1431 for the last single week of trading, and 1.4028 for the last 200 days.
Aravive Inc [ARAV]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Aravive Inc [ARAV] shares currently have an operating margin of -775.28 and a Gross Margin at +90.30. Aravive Inc’s Net Margin is presently recorded at -835.31.
Return on Total Capital for ARAV is now -223.71, given the latest momentum, and Return on Invested Capital for the company is -259.44. Return on Equity for this stock declined to -288.67, with Return on Assets sitting at -117.47. When it comes to the capital structure of this company, Aravive Inc [ARAV] has a Total Debt to Total Equity ratio set at 38.26. Additionally, ARAV Total Debt to Total Capital is recorded at 27.67, with Total Debt to Total Assets ending up at 6.56. Long-Term Debt to Equity for the company is recorded at 17.66, with the Long-Term Debt to Total Capital now at 12.77.
Reflecting on the efficiency of the workforce at the company, Aravive Inc [ARAV] managed to generate an average of -$3,318,348 per employee. Receivables Turnover for the company is 154.86 with a Total Asset Turnover recorded at a value of 0.14.Aravive Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.55 and a Current Ratio set at 1.55.
Aravive Inc [ARAV]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ARAV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Aravive Inc go to 70.53%.
An analysis of Institutional ownership at Aravive Inc [ARAV]
The top three institutional holders of ARAV stocks are: VANGUARD GROUP INC with ownership of 1.31 billion shares, which is approximately 8.2089%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $170.67 trillion in ARAV stocks shares; and BERKSHIRE HATHAWAY INC, currently with $150.98 trillion in ARAV stock with ownership which is approximately 5.7381%.